Glumetza Price Fixing $453M Class Action Settlement
“Three pharmaceutical companies agreed to pay a combined $453 million as part of a settlement to resolve claims that they suppressed generic versions of Glumetza. The settlement benefits entities who purchased generic or brand-name Glumetza directly from Bausch, Lupin, or Oceanside between May 6,” reports Top Class Actions in their blog.
“The following companies are excluded from the Class: Albertsons Companies Inc., Albertsons LLC, CVS Pharmacy Inc., H-E-B L.P., Humana Pharmacy Inc., Hy-Vee Inc., The Kroger Co., Rite Aid Corp., Rite Aid Hdqtrs. Corp., R&S Northeast LLC., and Walgreen Co. Glumetza is an extended release form of metformin used to treat type 2.”
